Since Knixwear was created in 2013, the company has sold over 1 million bras and pairs of underwear. The intimates brand broke Kickstarter records with the most funded fashion project in the history of the site. Their 8-in-1 evolution bra did $1.6 million in pre-sales.
Joanna Griffiths, Founder and CEO of Knixwear joins Cheddar to explain how she got the idea for her company. Griffiths wanted to create clothing that adapted to the needs of women. Knixwear has been committed to making active women intimates, and they classify intimates as anything that touches a person's skin.
In the coming months, Knixwear is looking to launch a t-shirt that will help manage underarm sweat. Griffiths said the company will also debut a heavy-duty sports bra that, the entrepreneur claims, will blow the competition out of the water.
Best Buy lowered its sales outlook for the rest of the year despite a positive quarterly earnings report.
X Corp, formerly known as Twitter, is facing over 2,200 arbitration cases.
Google Flight added a new feature that tracks flight prices.
Businesses posted far fewer open jobs in July and the number of Americans quitting their jobs fell sharply for the second straight month, clear signs that the labor market is cooling in a way that could reduce inflation.
American Airlines said it was fined $4.1 million for keeping passengers on planes during long on-ground delays.
3M said it will pay $6 billion to settle lawsuits claiming that it sold defective earplugs to the U.S. military.
Meta said it disrupted a campaign of disinformation linked to Chinese law enforcement.
Buying your first home can be challenging with rising interest rates and other costs. Cheddar News spoke with Amira Elgoneimy, a premiere agent with Redfin who caters to the New Brunswick, NJ area, and Daryl Fairweather, chief economist with Redfin, about the process involved in purchasing a residence in a competitive market.
Experts from Redfin real estate brokerage explain the challenges buyers are experiencing as they try to buy their first homes.
The Biden administration is targeting the blood thinner Eliquis, diabetes treatment Jardiance and eight other medications for Medicare's first-ever drug price negotiations as it seeks to lower medical costs for Americans.
